BMC Cancer (Nov 2022)

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

  • C. Martínez-Laperche,
  • L. Sanz-Villanueva,
  • F. J. Díaz Crespo,
  • P. Muñiz,
  • R. Martín Rojas,
  • D. Carbonell,
  • M. Chicano,
  • J. Suárez-González,
  • J. Menárguez,
  • M. Kwon,
  • J. L. Diez Martín,
  • I. Buño,
  • M. Bastos Oreiro

DOI
https://doi.org/10.1186/s12885-022-10335-7
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 2

Abstract

Read online

No abstracts available.